Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.

Authors :: Liles DK
Shah NR
Scullin B
Gordeuk VR
Smith WR
Kanter J
Achebe MM
Boccia R
Crary SE
Kraft WK
Archer N
Cataldo V
Hardesty BM
Idowu M
Desai PC
Ikeda A
Puthenveetil G
Hassell KL
Sarnaik S
Kutlar A
Source :: British journal of haematology [Br J Haematol] 2021 Nov; Vol. 195 (4), pp. e150-e153. Date of Electronic Publication: 2021 Oct 05.
Publication Year :: 2021

Subjects :: Acute Pain epidemiology
Acute Pain prevention & control
Anemia, Sickle Cell drug therapy
Arterial Occlusive Diseases epidemiology
Arterial Occlusive Diseases prevention & control
Clinical Trials as Topic statistics & numerical data
Follow-Up Studies
Humans
Incidence
P-Selectin antagonists & inhibitors
P-Selectin immunology
Acute Pain etiology
Anemia, Sickle Cell complications
Antibodies, Monoclonal, Humanized therapeutic use
Arterial Occlusive Diseases etiology

Full Text Access

Tools